News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Provectus Pharmaceuticals Inc. Release: Research on Mechanism of Action of Rose Bengal Presented at 8th World Congress of Melanoma


8/6/2013 7:35:50 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Provectus Pharmaceuticals, Inc. (OTCQB: PVCT, http://www.pvct.com), a development-stage oncology and dermatology biopharmaceutical company, announced that research exploring the mechanism of action of Rose Bengal was presented at the 8th World Congress of Melanoma, which took place July 17 – July 20, 2013 in Hamburg, Germany.

Hey, check out all the research scientist jobs. Post your resume today!

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES